Documentos relacionados

1. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence.
2. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
3. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
4. Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom.
5. Análisis de costo-efectividad de escitalopram comparado con paroxetina, sertralina y venlafaxina como terapia de mantenimiento para pacientes con trastorno de ansiedad generalizada en Colombia
6. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
7. Benefit of slow titration of paroxetine to treat depression in the elderly.
8. Fund Black scientists.
9. Análisis de costo-efectividad de escitalopram comparado con paroxetina, fluoxetina, sertralina, fluvoxamina y clomipramina como terapia de mantenimiento para pacientes con trastorno obsesivo compulsivo en Colombia
10. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.